Octreotide and bromocriptine in patients with stage D2 prostate cancer who relapsed during treatment with flutamide and castration.
Dupont
A
A
Boucher
H
H
Cusan
L
L
Lacourciere
Y
Y
Emond
J
J
Labrie
F
F
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001971:Bromocriptine / Q000008:administration & dosage; D006801:Humans; D008297:Male; D015282:Octreotide / Q000008:administration & dosage; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D001971:Bromocriptine; D015282:Octreotide